|
|
| Products |
Vaprisol (conivaptan hydrochloride) 20mg (to be presented)
|
|
| Supplier |
|
Cumberland Pharmaceuticals Inc. (USA) |
|
 |
|
|
| Strength |
20mg/100mL |
|
|
| Indication |
VAPRISOL® is indicated to raise serum sodium in hospitalized patients with euvolemic and hypervolemic hyponatremia.
Important Limitations:
VAPRISOL has not been shown to be effective for the treatment of the signs and symptoms of heart failure and is not approved for this indication.
It has not been established that raising serum sodium with VAPRISOL provides a symptomatic benefit to patients. |
|
|
|
|
|
|
